Description
DEOBLIGATION OF EXCESS FUNDS FOR CLOSEOUT
Base award description: T LYOMPHOCYTE SEQUENCING
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-06-07+$12,000= $12,000
- Mod P000012023-02-15+$12,000= $24,000
- Mod P000022023-02-19+$0= $24,000
- Mod P000032024-09-11-$524= $23,476
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-06-07 | +$12,000 | $12,000 | T LYOMPHOCYTE SEQUENCING |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-02-15 | +$12,000 | $24,000 | T LYOMPHOCYTE SEQUENCING |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2023-02-19 | +$0 | $24,000 | T LYOMPHOCYTE SEQUENCING - CHANGE ADMIN CO |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-09-11 | −$524 | $23,476 | DEOBLIGATION OF EXCESS FUNDS FOR CLOSEOUT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI QHHJD3X516J9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24E26N0214 | RPO EAST (36C24E) · Q301 · REFERENCE LABORATORY TESTING | $46,855 | FY2026 |
| 36C24E26D0011 | RPO EAST (36C24E) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2026 |
| 36C24E25N0115 | RPO EAST (36C24E) · AN45 · HEALTH R&D SERVICES; HEALTH CARE - OTHER; EXPENSES FOR R&D FACILITIES AND MAJOR EQUIPMENT | $97,585 | FY2025 |
| 36C24E24N0232 | RPO EAST (36C24E) · AN45 · HEALTH R&D SERVICES; HEALTH CARE - OTHER; EXPENSES FOR R&D FACILITIES AND MAJOR EQUIPMENT | $95,669 | FY2024 |
| 36C24224C0044 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · Q523 · MEDICAL- SURGERY | $4,713,142 | FY2024 |
| 36C24224P1488 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · AN11 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $27,880 | FY2024 |
Other recipients under AJ11 from 242-NETWORK CONTRACT OFFICE 02 (36C242) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24225P1363 | REGENTS OF THE UNIVERSITY OF MICHIGAN | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $317,340 | FY2025 |
| 36C24224P1273 | HEALTH RESEARCH, INC. | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $22,176 | FY2024 |
| 36C24224P1542 | FLUIDDA INC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $194,875 | FY2024 |
| 36C24224P0536 | EUROFINS DISCOVERY SERVICES NORTH AMERICA, LLC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $6,058 | FY2024 |
| 36C24223P1289 | NEUROSCIENCE ASSOCIATES INC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $9,760 | FY2023 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24222P0959_3600_-NONE-_-NONE- · retrieved 2026-09-26.